Where Are They Now? Q & A with Dr. Saeed Aldosari

By: Dr. Orbie Ubaka, PharmD, BCPS, BCIDP

Dr. Saeed Aldosari, PharmD, BCPS, BCIDP 

Dr. Aldosari is an Infectious Diseases Pharmacist and Health Outcomes Fellow at Nova Southeastern University College of Pharmacy. He completed his PGY-1 Pharmacy Practice Residency and PGY-2 Infectious Diseases Pharmacy Residency at Tufts Medicine MelroseWakefield Hospital, Melrose, MA. His interests include Antimicrobial stewardship, transitions of care, resistance modeling, diagnostic stewardship, and treatment outcomes research 

Research presented at the 2025 MAD-ID Annual Meeting:

Impact of Pharmacist and Case Management Collaboration on Antimicrobial Duration at Discharge in a Community Hospital Setting 

Dr. Aldosari conducted a retrospective pre-/post-intervention study evaluating a pharmacist- and case manager-led antimicrobial stewardship intervention focused on discharge antibiotic prescribing. The intervention significantly improved appropriate antibiotic duration and selection, reduced fluoroquinolone use, and demonstrated high prescriber acceptance, with the most pronounced improvements seen in urinary tract infection management. 

Questions 

1. What prompted you to evaluate antimicrobial stewardship at hospital discharge? 

During my clinical training, I consistently observed that antibiotic prescribing at discharge often lacked the same level of stewardship oversight as inpatient therapy, particularly with respect to duration and fluoroquinolone use. Given the growing evidence that discharge is a high-risk transition point, I saw an opportunity to design a practical, workflow-integrated intervention that addressed these gaps without adding significant burden to providers. 

2. How have the results of your study impacted your current practice? 

As an Infectious Diseases Pharmacy Fellow with a strong focus on clinical research, this study has shaped how I approach stewardship questions from both a practice and investigational perspective. It reinforced the importance of designing interventions that are pragmatic, workflow-integrated, and measurable. In my current role, I apply these principles by focusing on research that evaluates real-world antimicrobial use, transitions of care, and outcomes that matter to both patients and health systems. The high acceptance rate observed in this study also highlighted the value of interdisciplinary collaboration, which continues to inform how I design and evaluate stewardship-focused research initiatives. 

3. What findings from your study were most impactful? 

The most impactful finding was the dramatic improvement in urinary tract infection management, where appropriate treatment duration increased from 54% to 96%. This demonstrated that even simple, evidence-based tools can lead to substantial improvements when applied consistently at discharge. 

4. What unanswered questions remain following this work? 

Future research should assess whether these improvements translate into better patient-centered outcomes, such as reduced readmissions, adverse drug events, and Clostridioides difficile infection. Evaluating long-term sustainability and expanding this model across multiple community hospitals are also important next steps. 

5. Why is this research important for community hospitals? 

Community hospitals often face resource limitations that make traditional stewardship models challenging. This project shows that meaningful improvements can be achieved by leveraging existing team members and embedding stewardship into routine discharge workflows, making the approach both scalable and sustainable. 

The MAD-ID ‘Where Are They Now?’ series highlights research presented at the MAD-ID Annual Meeting now published in the infectious diseases literature.